Health & Safety

July 9, 2012

Neurotrauma, Psychological Health office partners with VA to study PTSD treatments

by Carey Phillips
Fort Detrick, Md.

Post-traumatic stress disorder is a common anxiety disorder that can stem from any traumatic event experienced by an individual.

While there are medications currently approved by the U.S. Food and Drug Administration to treat it, they are not sufficiently effective in treating combat-related post-traumatic stress commonly seen in service members and veterans.

The U.S. Army Medical Materiel Development Activity’s Neurotrauma and Psychological Health Project Management Office signed an interagency agreement with the Veterans Affairs Cooperative Studies Program, or VACSP, to jointly conduct and support clinical studies of pharmacotherapeutics for the treatment of combat-related Post-traumatic stress disorder, knowns as PTSD, in service members and veterans.

“The interagency agreement between USAMMDA and VACSP structures how the agencies will collaborate,” said Maj. Gary Wynn, research psychiatrist with the Neurotrauma and Psychological Health Project Management Office. “While the DOD may be funding the research effort, the VA is an equal partner in the project.”

“The VA is the primary location for Veterans to receive care so we need to be looking at their populations as well as those still on active duty,” he explained.

USAMMDA and VACSP will be working together to identify and develop alternate indications for existing FDA-approved drugs used to treat other disorders.

“While these drugs are FDA-approved, they are not approved for the treatment of PTSD,” said Wynn. “In fact, many of the drugs currently being used have little, or no research supporting their off-label use in treating PTSD.”

Currently, there are two drugs that are FDA-approved for treating PTSD. However, studies have shown that these drugs are less than 50 percent effective when it comes to treating combat-related PTSD. Additionally, the side effects from these drugs can be harmful to service members and veterans.

Although these drugs have helped victims of PTSD, worldwide they have shown limited benefit for service members and veterans struggling with the aftermath of combat.

“These studies are vital to understand if and how [the drugs in the collaborative USAMMDA and VACSP study] should be used in service members and veterans,” said Wynn.

According to Wynn, the collaboration between USAMMDA and the VA will ensure the highest quality of research.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines April 24, 2015

News: More than $1 billion in U.S. emergency reconstruction aid goes missing in Afghanistan - A total of $1.3 billion that the Pentagon shipped to its force commanders in Afghanistan between 2004 and 2014 for the most critical reconstruction projects can’t be accounted for by the Defense Department, 60 percent of all such spending under an...
 
 

News Briefs April 24, 2015

German defense minister: widely used rifle has no future A widely used assault rifle has “no future” with the German military in its current form, Germany’s defense minister said April 22, escalating a dispute over the weapon’s alleged shortcomings. Ursula von der Leyen said last month that a study showed the G36 rifle has a...
 
 
Army photograph

Composites key to tougher, lighter armaments

Army photograph XM-360 test firing at Aberdeen Proving Ground, Md., in 2007, is shown. The Army is on the cusp of revolutionizing materials that go into armament construction, making for stronger, lighter and more durable weapo...
 

 

Northrop Grumman signs long-term agreement with Raytheon

Northrop Grumman has entered a long-term agreement with Raytheon to supply its LN-200 Inertial Measurement Unit for Raytheon optical targeting systems. The long-term agreement with Raytheon’s Space and Airborne Systems business extends through 2018. The LN-200 provides camera stabilization on optical targeting systems that conduct long-range surveillance and target acquisition for various...
 
 

NTTR supports first F-35B integration into USMC’s weapons school exercise

The Nevada Test and Training Range was part of history April 21, when four U.S. Marine Corps-assigned F-35B Lightning IIs participated in its first Marine Corps’ Final Exercise of the Weapons and Tactics Instructor course on the NTTR’s ranges. The Final Exercise, or FINEX, is the capstone event to the U.S. Marine Corps Marine Aviation...
 
 
AAR-Textron

AAR awarded new contract from Bell Helicopter Textron to support T64 engines

AAR announced April 22 that Bell Helicopter Textron Inc. awarded its Defense Systems & Logistics business unit a contract providing warehouse and logistics services in support of upgrading T64 engines for the Bell V-280 Val...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>